These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2462815
1. Serum antibodies to peripheral nerve antigens in Guillain-Barré syndrome. Negishi T, Yamashita T, Nomura K, Hosokawa T, Ohno R, Hamaguchi K, Uyemura K. Ann N Y Acad Sci; 1988; 540():376-7. PubMed ID: 2462815 [No Abstract] [Full Text] [Related]
2. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation. Koski CL. Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928 [No Abstract] [Full Text] [Related]
3. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. Geczy C, Raper R, Roberts IM, Meyer P, Bernard CC. J Neuroimmunol; 1985 Aug; 9(3-4):179-91. PubMed ID: 2410449 [Abstract] [Full Text] [Related]
4. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RA. J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591 [Abstract] [Full Text] [Related]
5. Peripheral nerve P2 basic protein and the Guillain-Barré syndrome. In vitro demonstration of P2-specific antibody-secreting cells. Luijten JA, De Jong WA, Demel RA, Heijnen CJ, Ballieux RE. J Neurol Sci; 1984 Jul; 66(2-3):209-16. PubMed ID: 6085109 [Abstract] [Full Text] [Related]
6. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome. Koski CL. Ann Neurol; 1990 Jul; 27 Suppl():S44-7. PubMed ID: 2194426 [Abstract] [Full Text] [Related]
7. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. van Doorn PA, Brand A, Vermeulen M. Neurology; 1987 Nov; 37(11):1798-802. PubMed ID: 3670618 [Abstract] [Full Text] [Related]
13. Monoclonal antibodies to P2 basic protein and their use in the investigation of some aspects of the Guillain-Barré syndrome. Luijten JA, Reijneveld-de Jong SD, Teerlink T, Camps VT, Osterhaus AD, UytdeHaag AG. J Neurol Sci; 1988 Sep; 86(2-3):265-76. PubMed ID: 2464668 [Abstract] [Full Text] [Related]
14. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes. Goffette S, Jeanjean A, Pierret F, Peeters A, Sindic CJ. Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819 [Abstract] [Full Text] [Related]
15. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Quarles RH, Ilyas AA, Willison HJ. Ann Neurol; 1990 Dec; 27 Suppl():S48-52. PubMed ID: 2194427 [Abstract] [Full Text] [Related]
16. Antibody binding to PNS myelin proteins in acute Guillain-Barré syndrome. Shuman S, Zweiman B, Lisak R, Kahn S, Rostami A, Sumner A. Pathol Immunopathol Res; 1988 Dec; 7(3):162-8. PubMed ID: 3194353 [No Abstract] [Full Text] [Related]
17. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome. Vedeler CA, Nyland H, Fagius J, Osterman PO, Matre R, Aarli JA, Janzen RW, Jacobsen H, Skre H. J Neurol; 1982 Dec; 228(1):59-64. PubMed ID: 6184459 [Abstract] [Full Text] [Related]